Parsabiv® Etelcalcetide 2.5 mg / 0.5 mL Injection Single-Use Vial 0.5 mL

Compare

McKesson #

1219812

Manufacturer #

55513074010

Brand

Parsabiv®

Manufacturer

Amgen Inc (Nephrology)

Country of Origin

Germany

Application

Secondary Hyperparathyroidism (HPT) Treatment

Container Type

Single-Use Vial

Dosage Form

Injection

Generic Drug Name

Etelcalcetide

NDC Number

55513074010

Product Dating

McKesson Acceptable Dating: we will ship >= 180 days

Storage Requirements

Requires Refrigeration

Strength

2.5 mg / 0.5 mL

Type

Intravenous

UNSPSC Code

42161608

Volume

0.5 mL

Parsabiv® (etelcalcetide) is indicated for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis
PARSABIV (etelcalcetide) injection is supplied in a single-dose vial (type I glass) with stopper (fluoropolymer laminated elastomeric) and an aluminum seal with flip-off dust cover containing 5 mg/mL of etelcalcetide as a ready-to-use clear and colorless solution

View Full Comparison